- Karmastock
- uploaded: Nov 9, 2011
- Hits: 517
Description:
On its third quarter fiscal 2011 results, Salix Pharmaceuticals Limited - symbol SLXP - posted total product revenue of $146.2 million, an 81% increase year over year. The company has raised its 2011 Guidance
Tags:
Categories:
0 comments
No comments yet.











